Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156752 | SCV000206473 | uncertain significance | not specified | 2014-08-21 | criteria provided, single submitter | clinical testing | The Glu525Asp variant in VCL gene has not been previously reported in individual s with cardiomyopathy or in large population studies. Computational prediction t ools and conservation analysis do not provide strong support for or against an i mpact to the protein. In summary, the clinical significance of the Glu525Asp var iant is uncertain. |
Genetics and Genomics Program, |
RCV001293104 | SCV001434088 | uncertain significance | Hypertrophic cardiomyopathy | criteria provided, single submitter | research | ||
Labcorp Genetics |
RCV001481749 | SCV001686097 | likely benign | Dilated cardiomyopathy 1W | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390369 | SCV002703588 | benign | Cardiovascular phenotype | 2022-08-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |